R. Gantier et al., The pathogenic L392V mutation of presenilin 1 decreases the affinity to glycogen synthase kinase-3 beta, NEUROSCI L, 283(3), 2000, pp. 217-220
Determination of the effects of presenilin 1 (PSEN1) mutations, involved in
autosomal dominant early-onset Alzheimer's disease (ADEOAD), on the intera
ction between PSEN1 and binding proteins is essential to determine which in
teractions are involved in Alzheimer's disease (AD) pathogenesis. The PSEN1
binding protein glycogen synthase kinase-3 beta (GSK-3 beta) has been cons
idered as a key protein in AD pathogenesis since GSK-3 beta phosphorylates
tau and hyperphosphorylated tau is a main component of neurofibrillary tang
les associated to AD. We show here, using surface plasmonic resonance, that
the pathogenic L392V mutation, identified in a large French ADEOAD pedigre
e including 39 affected members, leads to a decreased affinity to GSK-3 bet
a. We conclude therefore that the increase of affinity of PSEN1 to GSK-3 be
ta reported in previous studies is not a common effect of pathogenic mutati
ons associated to ADEOAD. (C) 2000 Elsevier Science Ireland Ltd. All rights
reserved.